Correlation Engine 2.0
Clear Search sequence regions


  • 3 4, 5- dimethylthiazol- 2- yl) 2, 5- diphenyl ... (2)
  • actin (2)
  • adenocarcinoma (2)
  • aldehyde (4)
  • aldol (1)
  • alp (1)
  • angiogenesis (20)
  • anti- antibodies (2)
  • antibodies (2)
  • antitumor agents (1)
  • apaf 1 (2)
  • apoptosis (27)
  • appear (1)
  • BAX (24)
  • bax protein (1)
  • Bcl2 (21)
  • bcp (2)
  • bend (1)
  • bevacizumab (1)
  • blebs (1)
  • blood vessel (8)
  • cancer (20)
  • caspases (2)
  • cdna (3)
  • cell cycle (1)
  • cell death (9)
  • cell membrane (1)
  • cells b (3)
  • cells d (1)
  • cells growth (1)
  • cells polarity (1)
  • chick embryo (1)
  • chorioallantoic membrane (10)
  • chromatin (3)
  • cisplatin (16)
  • contain (1)
  • crystals (2)
  • cytokines (1)
  • cytoplasm (3)
  • D PARP (1)
  • decreases weight (2)
  • dithiothreitol (1)
  • dmso (4)
  • dna damage (1)
  • dye (1)
  • edta (1)
  • effects treatment (1)
  • egta (1)
  • ehrlich ascites carcinoma (44)
  • embryo (1)
  • empowers (1)
  • enzymes (2)
  • eosin (1)
  • ERK1 (1)
  • essential (1)
  • ethanol (1)
  • ethanol (1)
  • ether (2)
  • ethics committee (3)
  • factors (13)
  • factors receptor (1)
  • fibrin (1)
  • fibrosis splenic (2)
  • formazan (3)
  • gefitinib (1)
  • growth factors (3)
  • helps (1)
  • hematoxylin (1)
  • HIF 1α (13)
  • homeostasis (1)
  • HRP (3)
  • human (8)
  • hypoxia (1)
  • increases weight (1)
  • inhibitors enzymes (1)
  • inhibits (5)
  • integrin (1)
  • intestine (8)
  • JNK (10)
  • kaplan meier (1)
  • ligands (1)
  • liver (9)
  • liver function (1)
  • liver normal (3)
  • lung (11)
  • MAPK (16)
  • mapkk (1)
  • methanol (1)
  • mice (62)
  • microvessel (1)
  • mtt (6)
  • mtt- tetrazolium (1)
  • mucosa (3)
  • nuclear protein (1)
  • nuclear protein (1)
  • number cells (2)
  • oligo dt (1)
  • p38 mapk (3)
  • paraffin (1)
  • PARP (8)
  • PBS (2)
  • penicillin (1)
  • period (2)
  • powder (1)
  • present compound (1)
  • process (5)
  • profiles (1)
  • proteases (2)
  • protein level (4)
  • pvdf (1)
  • r t (1)
  • receptors (5)
  • regulates (1)
  • represses (1)
  • rna (2)
  • rt pcr (3)
  • segment (1)
  • serum (2)
  • signals (1)
  • silica gel (1)
  • slide (1)
  • sodium (2)
  • solvent (4)
  • sorafenib (1)
  • spleen (14)
  • stomach (3)
  • streptomycin (1)
  • suggests (2)
  • sunitinib (1)
  • suppress (1)
  • tetrazolium salt (1)
  • tie receptors (1)
  • toxic effects (1)
  • tris (1)
  • triton (1)
  • tumor metastasis (1)
  • tumor size (1)
  • understand (1)
  • urea (1)
  • vascular factor (1)
  • VEGF (15)
  • VEGFR (2)
  • VEGFR 1 (1)
  • vegfr- 2 (1)
  • vessels (2)
  • weight (10)
  • weight tumor (2)
  • western blot (5)
  • western blot (4)
  • β actin (2)
  • Sizes of these terms reflect their relevance to your search.

    In the present investigation, we synthesized chalcone bearing naphthalene compound d1, and on the basis of 1H-NMR, 13C NMR, and LC-MS data we had specified the structure of the synthesized compound. The resultant compound d1 was assessed for their antiproliferative action against human cancer cell lines (HeLa, HCT116, HT29, MDA-MB-231, MCF-7, and SKBR3). The IC50 range was estimated at 5.58 to 11.13 μM shows that compound d1 had remarkable anticancer activity on HeLa cell lines. Besides, it was discovered that d1 incited the mitochondrial apoptotic pathway by controlling Bax and Bcl-2 transcripts by expanding the Caspase 3 activation. We depicted the in-vivo effects of tumor advancement and the antiangiogenic activity of d1 in the EAC animal model. Tumor growth had inhibited and without symptoms the longevity of EAC containing mice expanded by the treatment of d1. Inhibition of nuclear transcriptional factor HIF-1α in EAC cells and finally it also inhibited phosphorylation of downstream signaling proteins such as ERK1/2, p38, and JNK in HeLa cells. The present investigation uncovered that d1 indicated noteworthy tumor-repressing abilities much less concentration in in-vitro and in-vivo recommended that compound d1 as the potent anticancer medication. Copyright: © 2020 Guruswamy et al.

    Citation

    Dileep Kumar M Guruswamy, Kyathegowdana Doddi Srivinavasa Balaji, Kattepura Krishnappa Dharmappa, Shankar Jayarama. Novel 3-(3, 5-difluoro-4-hydroxyphenyl)-1-(naphthalen-2-yl) prop-2-en-1-one as a potent inhibitor of MAP-kinase in HeLa cell lines and anti-angiogenic activity is mediated by HIF-1α in EAC animal model. Oncotarget. 2020 Dec 15;11(50):4661-4676


    PMID: 33400732

    View Full Text